Industry Outlook
The antimicrobial susceptibility test market had market size of 2,755.9 Mn in 2017 and will grow at a CAGR 4.7% and is anticipated to reach 4,159.2 Mn in 2026. World Health Organization (WHO) has stipulated stringent guidelines to life science industry and agriculturists to judiciously use antibiotics. Rising prevalence of infectious disease and looming threat of superbug infection drives the antimicrobial susceptibility market growth.
Market Synopsis
Get a sample copy for more information
"Availability of diverse range of test kits and easy interpretation propel its market growth"
Tests and Kits are presently reigning the product segment for antimicrobial susceptibility test market. Availability of diverse range of test kits and increasing health awareness regarding infectious disease resulting in early screening drive the tests and kits market growth. They are available as point of care diagnostic kits where in interpretation of results are quick and product is highly reliable and cost saving. There will be burgeoning requirement for culture media on account of flourishing biopharmaceutical industry and preservation of important cell lines and culture having therapeutic significance.
Get a sample copy for more information
"Increasing demand from clinical and epidemiology applications drive the disk diffusion method"
In the current scenario the disk diffusion method lead the method segment for antimicrobial susceptibility test market owing to its ability to determine the therapeutic efficacy and sensitivity of antibiotics towards different strains of bacteria. Increasing demand from clinical and epidemiological applications drive the market growth for disk diffusion method. Broth dilution method is gaining huge traction from food industry segment due to its potential to detect infection caused by microbes such as E.coli and Enterococcus.
"Rising prevalence of infectious disease and increasing number of patients suffering with antimicrobial resistance propel the antibacterial test market growth"
In the present scenario antibacterial test are dominating the test segment for antimicrobial susceptibility test market. The primary factors responsible for its dominance are rising prevalence of bacterial infection and increasing number of patients suffering with antimicrobial resistance. Scientist are striving earnestly to develop broad spectrum antibiotics. Antiparasitic tests will gain huge traction during the forecast period on account of huge health burden caused by parasitic infections such as malaria, dengue and encephalitis etc.
Get a sample copy for more information
"Increasing public health awareness regarding infectious disease propel the clinical diagnosis market growth"
Clinical diagnosis is currently leading the application segment for antimicrobial susceptibility test market. The major factors that propel the clinical diagnosis market growth are increasing public health awareness regarding infectious disease resulting in early screening. Huge investment spend by government healthcare agencies worldwide to provide effective diagnosis and precise treatment to curb the diagnosed infection. Drug discovery and development will showcase positive growth owing to the increasing threat caused by antibiotic resistance and rising demand for vaccines and biologics as a preventive measure against deadly infections.
"Rising prevalence of bacterial infection and increasing number of cases pertaining to antibiotic resistance will support the market growth in Asia Pacific region"
North America is leading the regional segment for antimicrobial susceptibility test market. According to the latest research citing presented by Center for Disease Control and Prevention (CDC) annually 2 million U.S. citizens are diagnosed with infectious disease resulting in death of approximately 25,000 people. Existence of well-developed healthcare infrastructure drive the market growth in North America. Supportive regulatory environment provided by European Medical Agency (EMA) and looming threat of antimicrobial resistance drive the market growth in Europe region. Asia Pacific serves as a lucrative market on account of rising prevalence of bacterial infection and burgeoning requirement for broad spectrum antibiotics to curb the spread of infectious diseases.
Historical & Forecast Period
This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.
The market segmentation for the report antimicrobial susceptibility test market is as follows:
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2016-2026 |
Base Year | 2017 |
Forecast Period | 2018-2026 |
Historical Year | 2016 |
Unit | USD Million |
Segmentation |
By Product (2016-2026; US$ Mn) |
By Method (2016–2026; US$ Mn) |
|
By Test (2016–2026; US$ Mn) |
|
By Application (2016–2026; US$ Mn) |
|
Geography Segment (2016–2026; US$ Mn) |
Pharmaceutical companies providing diagnostic kits for antimicrobial susceptibility test are Alifax Holding S.p.A., Bio-Rad Laboratories, Inc., bioMerieux, Biotron Healthcare, Becton Dickinson & Company, Danaher Corporation, HiMedia, Laboratories, Merck Group, Synbiosis and Thermo Fisher Scientific, Inc.